McGill University Health Centre news release
Thanks to antiretroviral therapy and improved control of viral hepatitis (HBV and HCV), people living with HIV generally live longer and healthier lives. However, liver disease remains common in this population and is one of the leading causes of death.
A large international study found that among people living with HIV, liver fibrosis, a build-up of scar tissue in the liver that can lead to permanent damage, is common, often has no symptoms and is frequently missed by the FIB-4 blood test, the first-line screening tool used in clinical practice. The study introduces the FIB-HIV score, a new tool that could improve the identification of people at risk of liver fibrosis by incorporating metabolic and HIV-specific factors. Effective detection of liver fibrosis is critical to ensure patients receive appropriate care.
Read the full news release here.
Source : McGill University Health Centre
Related HIV and Co-Infections News
-
UC San Francisco: Adults living with HIV are at high risk for diabetes. Here’s why.
-
[AIDS 2026] aidsmap: Returning to HIV care does not erase the effects of treatment interruption, studies show
-
[AIDS 2026] City St George’s, University of London: Risk of death 21% lower in people with HIV-related fungal disease given combination drug treatment
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.